cystine has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, J; Li, X; Liu, W; Long, M; Qiu, W; Su, H; Tang, Y; Wu, J | 1 |
| Alam, M; Hasegawa, M; Hiraki, M; Kufe, D; Maeda, T; Rajabi, H; Sukhatme, VP; Suzuki, Y; Tagde, A; Takahashi, H; Yin, L | 1 |
2 other study(ies) available for cystine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Selenocystine-induced cell apoptosis and S-phase arrest inhibit human triple-negative breast cancer cell proliferation.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cystine; Dose-Response Relationship, Drug; Female; Humans; Organoselenium Compounds; S Phase Cell Cycle Checkpoints; Triple Negative Breast Neoplasms | 2015 |
Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
Topics: Amino Acid Sequence; Amino Acid Transport System y+; Cell Proliferation; Cystine; Female; Glutamic Acid; Humans; Hyaluronan Receptors; Mucin-1; Oxidation-Reduction; Promoter Regions, Genetic; Reactive Oxygen Species; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2016 |